The Impact of NICU Music Therapy for Preterm Infants and Caregivers
Launched by ANGLIA RUSKIN UNIVERSITY · Feb 19, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the benefits of music therapy for premature infants in the Neonatal Intensive Care Unit (NICU) at the Whittington NHS Trust in the UK. The study aims to gather evidence on how music therapy can help both the babies and their primary caregivers, as this approach has shown positive results in other countries but hasn't been explored much in the UK. By doing this research, the trial hopes to encourage more hospitals to consider music therapy as a helpful, non-invasive treatment option for infants.
To take part in the study, infants need to be at least 28 weeks old and medically stable while staying in the NICU. Their primary caregivers, who will be asked to fill out questionnaires, must be able to communicate in English. The NICU staff involved must have a month of experience working there and at least two days of experience with music therapy during the study. While the study is not yet recruiting participants, it aims to create a supportive environment for both infants and caregivers through the soothing power of music.
Gender
ALL
Eligibility criteria
- Infant Participants:
- Inclusion Criteria:
- • Infants in or admitted to the Whittington NHS Trust NICU High Dependency Unit (HDU) during the 6-week intervention and data collection period
- • Infants are medically stable
- • Infants at 28 weeks corrected gestational age and above
- Exclusion Criteria:
- • Infants who are medically unstable
- • Infants younger than 28 weeks CGA
- • Severe hearing impairment or hearing loss
- Primary Caregivers:
- Inclusion criteria:
- • Primary caregiver(s) of an infant participating in the study
- • Ability to complete questionnaires in English
- • NICU Staff
- Inclusion criteria:
- • 1 month experience working at the Whittington NHS Trust NICU
- • At least two days' experience working on music therapy service provision days during the intervention period
About Anglia Ruskin University
Anglia Ruskin University is a leading higher education institution based in the United Kingdom, dedicated to advancing knowledge and innovation through research and collaboration. With a strong emphasis on applied research, the university engages in a variety of clinical trials aimed at improving health outcomes and enhancing patient care. Its multidisciplinary approach fosters partnerships with healthcare providers and industry stakeholders, ensuring that studies are grounded in real-world applications. Anglia Ruskin University is committed to ethical research practices, prioritizing participant safety and well-being while striving to contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jonathan Pool, PhD
Principal Investigator
Anglia Ruskin University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported